IrsiCaixa is a leading research institute in infection and immunity. Established in 1995 with the aim of finding a solution to the then devastating HIV/AIDS pandemic, IrsiCaixa seeks solutions to viral, bacterial, and fungal infections through its accumulated knowledge in immunology and vaccines. At the same time, it addresses other cross-disciplinary biomedical challenges, such as the microbiome, cancer, Alzheimer’s, or aging, among others.
Official website: http://www.irsicaixa.es/en